comparemela.com

Latest Breaking News On - Oren livnat hc wainwright co - Page 1 : comparemela.com

VYNE Therapeutics Inc. (VYNE) Q2 2021 Earnings Call Transcript

VYNE Therapeutics Inc. (VYNE) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

Australia
United-kingdom
United-states
Scotland
Oren-livnat
Mutya-harsch
Iain-stuart
Piper-sandler
Patrick-dolezal-lifesci
Patrick-dolezal
Louise-chen
Balaji-prasad

Agile Therapeutics (AGRX) Q2 2021 Earnings Call Transcript

Agile Therapeutics (AGRX) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

Oren-livnat
Tim-lugo
Dennis-reilly
Loestrin-fe
Matt-riley
Al-altomari
William-blair
Bloomberg
Sterling
Oren-livnat-hc-wainwright-co
Agile-therapeutics

MannKind Corporation (MNKD) Q1 2021 Earnings Call Transcript

Operator Good afternoon, and welcome to MannKind Corporation first-quarter 2021 earnings call. As a reminder this call is being recorded on May 12th, 2021, and will be available for playback on the MannKind Corporation website shortly after the conclusion of this call until May 26, 2021. This call will contain forward-looking statements. Such forward-looking statements are subject to risks and uncertainties which could cause actual results to differ materially from these stated expectations. For further information on the company s risk factors please see their 10-Q report filed with the Securities and Exchange Commission this morning, the earnings release and the slides prepared for this presentation. Joining us today from Mannkind are Chief Executive Officer Michael Castagna, and Chief Financial Officer Steven Binder. I would now like to turn the conference over to Mr. Castagna.

Boston
Massachusetts
United-states
Australia
India
Canada
Denver
Colorado
Oren-livnat
Steven-binder
Michael-castagna
Stephen-lichtman

VYNE Therapeutics Inc. (VYNE) Q4 2020 Earnings Call Transcript

VYNE Therapeutics Inc. (VYNE) Q4 2020 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. VYNE Therapeutics Inc. (NASDAQ: VYNE) Q4 2020 Earnings Call Good morning and welcome to the VYNE Therapeutics conference call to discuss the fourth-quarter and full-year 2020 financial results and update. [Operator instructions] Following the company s formal remarks, we will open the call for your questions. Please be advised that this call is being recorded at the company s request. I will now turn the call over to Michael Wood of LifeSci Advisors. Please go ahead. LifeSci Advisors Managing Director Good morning, everyone, and thanking thank you for joining us this morning. Before we begin with formal remarks, let me remind you that some of the information in the press release issued this morning and on this conference call contain forward-looking statements that involve risks, uncertainties, and assum

United-states
Israel
Israeli
Oren-livnat
Iain-stuart
Balaji-prasad-barclays
Matt-wiley
Balaji-prasad
Tim-chiang-northland
Carvey-leung-cantor-fitzgerald
Tim-chiang
Michael-wood-lifesci

MannKind Corporation (MNKD) Q4 2020 Earnings Call Transcript

MannKind Corporation (MNKD) Q4 2020 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. MannKind Corporation (NASDAQ: MNKD) Operator Good morning, and welcome to MannKind Corporation fourth-quarter and full-year 2020 earnings call. As a reminder, this call is being recorded on February 25, 2021, and will be available for playback on the MannKind Corporation website shortly after the conclusion of this call until March 11, 2021. This call will contain forward-looking statements. Such forward-looking statements are subject to risk and uncertainty, which could cause actual results to differ materially from these stated expectations. For further information on the company s risk factors, please see their 10-K report filed with the Securities and Exchange Commission this morning, the earnings release and the slides prepared for this presentation. Joining us today for MannKind are chief executive officer, M

Brazil
Australia
India
Oren-livnat
Steven-binder
Michael-castagna
Brandon-folkes-cantor-fitzgerald
Dylan-dupuis
Robert-hazlett
Steven-lichtman
Val-mann
Thomas-smith

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.